Hepatosplenic Tuberculosis on Pretherapy and Posttherapy FDG PET/CT
- PMID: 31876801
- DOI: 10.1097/RLU.0000000000002858
Hepatosplenic Tuberculosis on Pretherapy and Posttherapy FDG PET/CT
Abstract
A 65-year-old woman underwent FDG PET/CT for presumed hepatosplenic malignancy suggested by an abdominal CT. The images revealed multiple foci of intense FDG activity in both the liver and the spleen. However, a splenic biopsy result revealed no malignant cells, and either tuberculosis or sarcoidosis was proposed. Following an incomplete antituberculosis therapy, a repeat FDG PET/CT showed resolution of the abnormal activity in the liver and the spleen.
References
-
- Liu E, Wang S, Lai P, et al. “Hepatic Superscan” in a patient with hepatosplenic alphabeta T-cell lymphoma: 18F-FDG PET/CT findings. Clin Nucl Med. 2018;43:595–598.
-
- Quak E, Salaun V, Le Naoures C, et al. 18F-FDG PET/CT in hepatosplenic gamma-delta T-cell lymphoma. Clin Nucl Med. 2015;40:730–731.
-
- Dubreuil J, Leenhardt J, Noel R, et al. Isolated hepatosplenic sarcoidosis: a pitfall for lymphoma evaluation by (18)F-FDG PET/CT. Rev Esp Med Nucl Imagen Mol. 2017;36:399–400.
-
- Kraft KE, Doedens RA, Slart RH. Hepatosplenic cat-scratch disease in children and the positive contribution of 18F-FDG imaging. Clin Nucl Med. 2015;40:746–747.
-
- Albano D, Bosio G, Bertoli M, et al. Hepatosplenic candidiasis detected by (18)F-FDG-PET/CT. Asia Ocean J Nucl Med Biol. 2016;4:106–108.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
